Insights from 2024 ASCO® GI Annual Meeting


 

INSIGHT: A Phase 3 Study of Ripretinib vs. Sunitinib in Pts With Advanced GIST Previously Treated With Imatinib With KIT Exon 11 + 17/18 Mutations

110 views
March 20, 2024
0 Comments
Login to view comments. Click here to Login
Videos